Prandin 2 mg tablets

Illustration Prandin 2 mg tablets
Substance(s) Repaglinide
Admission country United Kingdom
Manufacturer Novo Nordisk A/S
Narcotic No
ATC Code A10BX02
Pharmacological group Blood glucose lowering drugs, excl. insulins

Authorisation holder

Novo Nordisk A/S

Drugs with same active substance

Drug Substance(s) Authorisation holder
Repaglinide Krka 1 mg tablets Repaglinide Krka, D.D., Novo Mesto
Prandin 1 mg tablets Repaglinide Novo Nordisk A/S
Repaglinide Krka 0.5 mg tablets Repaglinide Krka, D.D., Novo Mesto
Repaglinide Krka 2 mg tablets Repaglinide Krka, D.D., Novo Mesto
Repaglinide Teva 0.5 mg tablets Repaglinide Teva Pharma B.V.

Patient’s Leaflet

What is it and how is it used?

Prandin is an oral antidiabetic agent containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar (glucose).

Type 2 diabetes is a disease in which your pancreas does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces (formerly known as non-insulin-dependent diabetes mellitus or maturity onset diabetes).

Prandin is used to control type 2 diabetes as an add-on to diet and exercise: treatment is usually started if diet, exercise and weight reduction alone have not been able to control (or lower) your blood sugar. Prandin can also be given with metformin, another medicine for diabetes.


What do you have to consider before using it?

Do not take Prandin:
  • If you are hypersensitive (allergic) to repaglinide or any of the other components of the medicine
  • If you have type 1 diabetes ( insulin-dependent diabetes)
  • If the acid level in your body is raised (diabetic ketoacidosis)
  • If you have a severe liver disease
  • If you take gemfibrozil (a medicine used to lower increased fat levels in the blood).

If any of these apply to you, tell your doctor and do not take Prandin.

Take special care with Prandin:
  • If you have liver problems. Prandin is not recommended in patients with moderate liver disease. Prandin should not be taken if you have a severe liver disease (see Do not take Prandin).
  • If you have kidney problems. Prandin should be taken with caution.
  • If you are about to have major surgery or you have recently suffered a severe illness or infection. At such times diabetic control may be lost.
  • If you are under 18 or over 75 years of age. Prandin is not recommended. It has not been studied in these age groups.

Talk to your doctor if any of the above applies to you. Prandin may not be suitable for you. Your doctor will advise you.

If you get a hypo

You may get a hypo (short for a hypoglycaemic reaction and is symptoms of low blood sugar) if your blood sugar gets too low. This may happen:

  • If you take too much Prandin
  • If you exercise more than usual
  • If you take other medicines or suffer from liver or kidney problems (see other sections of 2. Before you take Prandin).

The warning signs of a hypo may come on suddenly and can include: cold sweat; cool pale skin; headache; rapid heart beat; feeling sick; feeling very hungry; temporary changes in vision; drowsiness; unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating.
If your blood sugar is low or you feel a hypo coming on: eat glucose tablets or a high sugar snack or drink, then rest.
When symptoms of hypoglycaemia have disappeared or when blood sugar levels are stabilised continue Prandin treatment.
Tell people you have diabetes and thatif you pass out (become unconscious) due to a hypo, they must turn you on your side and get medical help straight away. They must not give you any food or drink.It could choke you.

  • If severe hypoglycaemia is not treated, it can cause brain damage (temporary or permanent) and even death.
  • If you have a hypo that makes you pass out, or a lot of hypos, talk to your doctor. The amount of Prandin, food or exercise may need to be adjusted.
If your blood sugar gets too high

Your blood sugar may get too high (hyperglycaemia). This may happen:

  • If you take too little Prandin
  • If you have an infection or a fever
  • If you eat more than usual
  • If you exercise less than usual.

The warning signs appear gradually. They include: increased urination; feeling thirsty; dry skin and dry mouth. Talk to your doctor. The amount of Prandin, food or exercise may need to be adjusted.

Using other medicines

You can take Prandin with metformin, another medicine for diabetes, if your doctor prescribes it. If you take gemfibrozil (used to lower increased fat levels in the blood) you should not take Prandin.

Your body?s response to Prandin may change if you take other medicines, especially these:

  • Monoamine oxidase inhibitors (MAOI) (used to treat depression)
  • Beta blockers (used to treat high blood pressure or heart conditions)
  • ACE-inhibitors (used to treat heart conditions)
  • Salicylates (e.g. aspirin)
  • Octreotide (used to treat cancer)
  • Nonsteroidal anti-inflammatory drugs (NSAID) (a type of painkillers)
  • Steroids (anabolic steroids and corticosteroids ? used for anemia or to treat inflammation)
  • Oral contraceptives (birth control pills)
  • Thiazides (diuretics or ?water pills?)
  • Danazol (used to treat breast cysts and endometriosis)
  • Thyroid products (used to treat low levels of thyroid hormones)
  • Sympathomimetics (used to treat asthma)
  • Clarithromycin, trimethoprim, rifampicin (antibiotic medicines)
  • Itraconazole, ketokonazole (antifungal medicines)
  • Gemfibrozil (used to treat high blood fats)
  • Ciclosporin (used to suppress the immune system)
  • Phenytoin, carbamazepine, phenobarbital (used to treat epilepsy)
  • St. John?s wort (herbal medicine).

Tell your doctor if you have recently taken or are planning to take any of these medicines, or any medicines obtained without a prescription.

Using Prandin with food and drink

Take Prandin before main meals. Alcohol can change the ability of Prandin to reduce the blood sugar. Watch for signs of a hypo.

Pregnancy and breast-feeding

You should not take Prandin if you are pregnant or you are planning to become pregnant. See your doctor as soon as possible if you become pregnant or are planning to become pregnant during treatment.

You should not take Prandin if you are breast-feeding.

Driving and using machines

Your ability to drive or operate a machine may be affected if your blood sugar is low or high. Bear in mind that you could endanger yourself or others. Please ask your doctor whether you can drive a car if you:

  • Have frequent hypos
  • Have few or no warning signs of hypos.


How is it used?

Your doctor will work out your dose.

  • The normal starting dose is 0.5 mg before each main meal. Swallow the tablets with a glass of water immediately before or up to 30 minutes before each main meal.
  • The dose may be adjusted by your doctor by up to 4 mg to be taken immediately before or up to 30 minutes before each main meal. The maximum recommended daily dose is 16 mg.

Do not take more Prandin than your doctor has recommended. Always take Prandin exactly as your doctor has told you. Check with your doctor if you are not sure.

If you take more Prandin than you should

If you take too many tablets, your blood sugar may become too low, leading to a hypo. Please see If you get a hypo on what a hypo is and how to treat it.

If you forget to take Prandin

If you miss a dose, take the next dose as usual - do not double the dose.

If you stop taking Prandin

Be aware that the desired effect is not achieved if you stop taking Prandin. Your diabetes may get worse. If any change of your treatment is necessary contact your doctor first.

If you have any further questions on the use of Prandin, ask your doctor or pharmacist.


What are possible side effects?

Like all medicines, Prandin can cause side effects, although not everybody gets them.

Possible side effects

Common (may affect up to 1 in 10 patients)

  • Hypoglycaemia (see If you get a hypo). The risk of getting a hypo may increase if you take other medicines
  • Stomach pain
  • Diarrhoea.

Rare (may affect up to 1 in 1000 patients)

  • Acute coronary syndrome (but it may not be due to the drug).

Very rare (may affect up to 1 in 10,000 patients)

  • Allergy (such as swelling, difficulty in breathing, rapid heart beat, feeling dizzy, sweating which could be signs of anaphylactic reaction). Contact a doctor immediately
  • Vomiting
  • Constipation
  • Visual disturbances
  • Severe liver problems, abnormal liver function, increased liver enzymes in your blood.
Frequency unknown
  • Hypoglycaemic coma or unconsciousness (very severe hypoglycaemic reactions ? see If you get a hypo). Contact a doctor immediately
  • Hypersensitivity (such as rash, itchy skin, redening of the skin, swelling of the skin)
  • Feeling sick (nausea).

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor.


How should it be stored?

Keep out of the reach and sight of children.
Store in a dry place in order to protect from moisture. Store in the original package.

Do not use after the expiry date. The expiry date refers to the last date of that month. This is stated on the outer carton and the blister foil.

Medicines should not be disposed of down the drain or in household rubbish. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.


Further information

What Prandin contains

The active substance is repaglinide.
The other ingredients are:
Microcrystalline cellulose (E460), calcium hydrogen phosphate anhydrous, maize starch, amberlite (polacrilin potassium), povidone (polyvidone), glycerol 85%, magnesium stearate, meglumine, poloxamer, iron oxide yellow (E172) only in the 1 mg tablets and iron oxide red (E172) only in the 2 mg tablets.

Three strengths of tablets are available. The strengths are 0.5 mg, 1 mg and 2 mg.

What Prandin looks like and contents of the pack

Prandin tablets are round and convex and engraved with the Novo Nordisk logo (Apis bull). 0.5 mg tablets are white, 1 mg tablets are yellow and 2 mg tablets are peach-coloured. Four blister pack sizes are available. Each pack contains 30, 90, 120 or 270 tablets.
Not all pack sizes may be marketed.

Marketing authorisation holder and manufacturer

Novo Nordisk A/S
Novo Allé, DK-2880 Bagsværd, Denmark.

This leaflet was last approved in

Further Information

For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder.

Lietuva Novo Nordisk Pharma UAB A. Mickeviciaus str. 2 LT 08119 Vilnius Tel. 370 5 212 2849 BelgiëBelgiqueBelgien sa Novo Nordisk Pharma nv Boulevard International 55 Internationalelaan 55 B-1070 BruxellesBrussel TélTel 32 2556 0580


sa Novo Nordisk Pharma nv
Boulevard International 55
B-1070 Bruxelles
Tél/Tel: + 32 2556 0580

---- ------- ----- ---
--. ?------ ---? - 20-22
----- 1407.
---: + 359 2962 7471


Novo Nordisk Hungária Kft.
Fels-zöldmáli út. 35
H-1025 Budapest
Tel.: +36 1 3259 161

-eská republika

Novo Nordisk s.r.o.
Evropská 33c
CZ 160 00 Praha 6
Tel: +420 2 33 08 96 11

Danmark Novo Nordisk AS Novo Allé Malta handled by NNF Italy Novo Nordisk Farmaceutici S.p.A. Via Elio Vittorini 129

DK-2880 Bagsværd Tlf 45 45 88 08 00 I-00144 Rome Italy Tel 39 06 500881 Deutschland Novo Nordisk Pharma GmbH Brucknerstraße 1 D-55127 Mainz Tel 49 6131 903 115 Nederland Novo Nordisk B.V. Flemingweg 18 NL-2408 AV Alphen ad Rijn Tel 31 172 449 494


Novo Nordisk A/S Eesti filiaal
Paldiski mnt 27
EE - 10612 Tallinn
Tel: +372 667 50 50


Novo Nordisk Scandinavia AS Postboks 24
N-1309 Rud
Tlf: + 47 67 17 85 00


Novo Nordisk Hellas Ltd.
??. ??????-?? 80 & ??. ???-??? 65
GR-153 43 ??. ????????-
???: + 30 210 6071600


Novo Nordisk Pharma GmbH Opernring 3
A-1010 Vienna
Tel: + 43 1 405 15 01

España Laboratorios Menarini, S.A. c Alfonso XII, 587 E-08918 Badalona Barcelona Tel 34 93 4628800 Polska Novo Nordisk Pharma Sp. z o.o. ul. 17 Stycznia 45 Budynek B PL 02 146 Warszawa Tel. 48 22 444 49 00 France Novo Nordisk Cur Défense 100, avenue du Général de Gaulle 92400 Courbevoie Tél 33 1 41 97 66 00 Portugal Novo Nordisk, Lda. Quinta da Fonte Edificio D. José, Q54 - Piso 1 Porto Salvo P-2780-730 Paco de Arcos Tel 351 21 440 4000 Ireland Novo Nordisk Limited 34 Upper Pembroke Street IRL - Dublin 2 Tel 353 1 678 5989 România Novo Nordisk Farma SRL Str. Academiei nr. 28-30, etaj 5 Bucureti 010016 RO Tel 40 2 1312 3674 Ísland Vistor hf. Hörgatúni 2 IS-210 Garðabæ Sími 354 535 7000 Slovenija Novo Nordisk d.o.o. martinska cesta 140 SI-1000 Ljubljana Tel 386 1 585 1900 Italia Novo Nordisk Farmaceutici S.p.A. Via Elio Vittorini 129 I-00144 Roma Tel 39 06 500 881 Slovenská republika Novo Nordisk Slovakia s.r.o. ilinská 7-9 SK-811 05 Bratislava Tel 421 2 5710 3011 Generica Pharmaceutical Products Trading Co Ltd. 5A .. 3604 SuomiFinland Novo Nordisk Farma Oy

357 25 356585 Hevosenkenkä 3Hästskon 3 FI-02600 EspooEsbo PuhTel 358-20-762 5300 Latvija Novo Nordisk AS Representative Office Latvia Maskavas str 240 Riga, LV 1063 Tel 371 7257577 Sverige Novo Nordisk Scandinavia AB Box 50587 S-202 15 Malmö Tel 46 040 38 89 00

United Kingdom Novo Nordisk Limited Broadfield Park Brighton Road
Crawley RH11 9RT - UK West Sussex
Tel: +44 (0) 1293 613555


Substance(s) Repaglinide
Admission country United Kingdom
Manufacturer Novo Nordisk A/S
Narcotic No
ATC Code A10BX02
Pharmacological group Blood glucose lowering drugs, excl. insulins



Your personal medicine assistent

afgis-Qualitätslogo mit Ablauf Jahr/Monat: Mit einem Klick auf das Logo öffnet sich ein neues Bildschirmfenster mit Informationen über medikamio GmbH & Co KG und sein/ihr Internet-Angebot: This website is certified by Health On the Net Foundation. Click to verify.

Search our database for drugs, sorted from A-Z with their effects and ingredients.


All substances with their common uses, chemical components and medical products which contain them.


Causes, symptoms and treatment for the most common diseases and injuries.

The contents shown do not replace the original package insert of the medicinal product, especially with regard to dosage and effect of the individual products. We cannot assume any liability for the correctness of the data, as the data was partly converted automatically. A doctor should always be consulted for diagnoses and other health questions. Further information on this topic can be found here.